Evaluation of Pharmacokinetics, Safety, and Preliminary Efficacy of Isatuximab in Chinese Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT03733717 · COMPLETED
Trial details
- NCT number
- NCT03733717
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-22
- Primary completion
- 2020-09-06
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.